Dr Reddys Laboratories
BSE: 500124 | NSE: DRREDDY | ISIN: INE089A01023 | SECTOR: Biotechnology & DrugsOpen
4,370.05High
4,375.35Low
4,290.00Prev Close
4,399.90P/E
-Median P/E
-P/B
-Median P/B
-Market Cap
-Volume
3.94KVol. (20 day Avg.)
0PEG
-
- 4,290.00
- Intraday
- 4,375.35
- 3,655.00
- 52 Wk H/L
- 5,613.65
- 3,959.95
- DPR
- 4,839.85
Key Metrics
- Mkt. Cap.
Volatility %
Market Sentiment
- Moderately Positive
Beta -
Genie Says
Influencer Count
20Peer Comparison
- Price Comparison
- Ratios Comparison
Company | Latest Price Change (% Chg) | 52 Week High | 52 Week Low | Market Cap. (Cr) |
---|
Events
- Dividends
- Bonus
- Splits
- Rights
- Board Meetings
- Annual General Meetings
Simple Moving Averages
Days | BSE | NSE |
---|
Dr Reddys Laboratories is trading higher than 5 day, 20 day, 100 day and 200 day moving averages.
News
Company Description
- Large Cap
- Automobiles
BSE
500124NSE
DRREDDYISIN
INE089A01023
Dr. Reddy's Laboratories Limited is an India-based pharmaceutical company. The Company’s segments include Global Generics, which is engaged in manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics); Pharmaceutical Services and Active Ingredients (PSAI), which is engaged in manufacturing and marketing active pharmaceutical ingredients and intermediates for finished pharmaceutical products; Proprietary Products, which focuses on research and development of differentiated formulations and Others, which consists of the Company’s wholly-owned subsidiary, Aurigene Discovery Technologies Limited, which is a discovery stage biotechnology company developing novel and therapies in the fields of oncology and inflammation.
Company Officers
Satish Reddy
Chairman of the BoardG.V. Prasad
Co-Chairman of the Board, Managing DirectorErez Israeli
Chief Executive OfficerParag Agarwal
Chief Financial OfficerPatrick Aghanian
Chief Executive Officer, European GenericsMarc Kikuchi
Chief Executive Officer, North America GenericsM. Ramana
Chief Executive Officer, Branded Markets (India and Emerging Markets)Archana Bhaskar
Chief Human Resource OfficerMukesh Rathi
Chief Digital and Information OfficerK. Randhir Singh
Chief Compliance Officer, Company Secretary